Institutional Development Award (IDeA) for Clinical & Translational Research (CTR)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for research institutions building clinical and translational research capacity. Eligible applicants include domestic academic institutions, research organizations, and hospitals. Priority goes to IDeA-eligible institutions located in low-research-activity states. Projects must focus on translating basic science into clinical applications or improving patient care delivery. Geographic scope is limited to U.S.-based institutions in designated states. Funded activities include research infrastructure, investigator development, and collaborative networks.
Public and private nonprofits, small businesses, and state/local governments may apply. Institutions must demonstrate institutional commitment and match funding. The program strengthens research capacity in under-resourced regions.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- Nov 19, 2025 Applications open
- Oct 9, 2026 Application deadline in 84 days
- Jul 16, 2027 Award announced
- Jul 16, 2027 Project start
Program description
The Institutional Development Award program develops biomedical research capacity in states that have historically received low levels of NIH funding (IDeA states). The IDeA Clinical & Translational Research (CTR) Notice of Funding Opportunity supports two programmatic tracks to build clinical and translational research capacity to enable research on diseases and health challenges prevalent in IDeA states. IDeA Clinical and Translational Research Development (CTR-D) awards focus on clinical and translational research workforce development and infrastructure enhancement at health research organizations in IDeA states that have limited clinical research capacity. IDeA Clinical & Translational Research Network (CTR-N) awards support statewide or multi-state networks of health research organizations to expand existing infrastructure, develop the research workforce to enhance the network organization’s ability to design and implement competitive clinical and translational research programs, and coordinate clinical research activities state-wide and/or across IDeA states.
Who can apply
Eligible applicants
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (R&R) Cover Sheet
- Project Narrative (Research Strategy and Translational Plan)
- Budget Justification
- Institutional Support and Cost-Share Documentation
- Biosketches of Key Personnel
- Letters of Support from Institutional Leadership
Program contact
- 👤 NIGMS IDeA CTR
- 📧 NIGMS_IDeA-CTR@mail.nih.gov
- 📞 Please contact via e-mail
Funding track record
Recent awards under CFDA 93.859 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$59,464,779
-
$57,271,194
-
$56,019,458
-
$54,912,096
-
$53,329,877
-
$52,858,544
-
$52,347,059
-
$52,026,661
-
$50,897,104
-
$49,349,731
Top States by Funding
- ME 4 awards $143.3M
- MS 4 awards $135.1M
- NY 5 awards $131.6M
- CA 5 awards $129.3M
- RI 4 awards $126.3M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.859). How funding has trended year over year.
| 2024 | $3,085,929,426 | |
| 2025 | $3,092,472,727 | |
| 2026 est. | $3,093,422,000 |
FAQ
Which institutions are eligible for this grant?
Public and private universities, research hospitals, and other domestic research institutions qualify. IDeA-eligible institutions in low-research-activity states have priority.
What types of projects are funded?
Clinical and translational research projects that move discoveries into practice are supported. Investigator development and research infrastructure improvements also qualify.
Does my institution need to provide matching funds?
Yes, institutional cost-share or matching funds are typically required. The exact percentage varies by program requirements.
How competitive is this funding?
This is a moderately competitive program. Strong applications show institutional support, preliminary data, and realistic timelines.
What is the typical funding range?
Grants typically range from $500K to several million over multiple years. Award amounts depend on project scope and institution capacity.
💡 Tips for applicants
- Demonstrate strong institutional commitment through leadership support letters and dedicated resources.
- Start with pilot data or preliminary results showing feasibility of your translational research.
- Connect your project to unmet clinical needs or health disparities in your region.
- Build partnerships with established research centers to strengthen your application.
- Align your proposal with NIH strategic priorities in translational science and precision medicine.
⚠️ Common mistakes
Weak institutional commitment or unclear cost-share details often derail applications. Vague translation pathways from research to clinical practice reduce competitiveness. Insufficient preliminary data or unrealistic timelines signal poor planning.
Similar grants
- OPEN Single Source: Institutional Development Award (IDeA) Clinical Research Resource Center (I-CRRC) — National Institutes of Health
- OPEN Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (Clinical Trials Optional) — National Institutes of Health
- OPEN Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional) — National Institutes of Health
- OPEN Clinical and Translational Science Award (UM1 Clinical Trial Optional) — National Institutes of Health
- OPEN Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 – Clinical Trial Not Allowed) — National Institutes of Health